Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug-Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA).
Fagiuoli S, Toniutto P, Coppola N, Ancona DD, Andretta M, Bartolini F, Ferrante F, Lupi A, Palcic S, Rizzi FV, Re D, Alvarez Nieto G, Hernandez C, Frigerio F, Perrone V, Degli Esposti L, Mangia A.
Fagiuoli S, et al. Among authors: degli esposti l.
Ther Clin Risk Manag. 2023 Jan 18;19:57-65. doi: 10.2147/TCRM.S394467. eCollection 2023.
Ther Clin Risk Manag. 2023.
PMID: 36699017
Free PMC article.